Machine Learning

Romania's new 1,500km quantum network, powered by IonQ, marks a major step in Europe's race to secure critical data against future cyber threats.

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

With $62B in 2025 funding and a 17% surge, Origence is arming credit unions with AI and embedded finance to compete in a rapidly changing market.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

With the hire of Amazon and NBCU veteran Krishan Bhatia, Taboola signals an aggressive push to dominate performance advertising beyond search and social.

As AI data centers grow more complex, a new wave of intelligent management tools emerges. KAYTUS's KSManage promises to shift from reactive fixes to predictive foresight.

A novel mouse model with human immune receptors promises to slash the high failure rate of antibody therapies, accelerating life-saving treatments.

Huawei's new AI Calling solution promises real-time translation and smart assistants, but can global networks and privacy standards keep up with innovation?

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

Quantum firm IonQ shatters revenue goals with $130M in 2025 and moves to acquire a chip foundry, signaling an aggressive push to own the quantum stack.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

A landmark summit in New Delhi launches a strategic tech partnership, aiming to build a sovereign 'third way' in AI and challenge global power dynamics.

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.